Logo image of SHL.DE

SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock

42.33 EUR
-0.34 (-0.8%)
Last: 12/3/2025, 5:36:15 PM
Fundamental Rating

5

Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 65 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
SHL had a positive operating cash flow in each of the past 5 years.
SHL.DE Yearly Net Income VS EBIT VS OCF VS FCFSHL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.83%, SHL is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
With a decent Return On Equity value of 11.88%, SHL is doing good in the industry, outperforming 66.15% of the companies in the same industry.
SHL's Return On Invested Capital of 7.65% is in line compared to the rest of the industry. SHL outperforms 60.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.72%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROIC 7.65%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
SHL.DE Yearly ROA, ROE, ROICSHL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

SHL has a Profit Margin of 9.17%. This is in the better half of the industry: SHL outperforms 63.08% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
SHL has a Operating Margin of 13.53%. This is comparable to the rest of the industry: SHL outperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL has a worse Gross Margin (38.63%) than 80.00% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
SHL.DE Yearly Profit, Operating, Gross MarginsSHL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
SHL has more shares outstanding than it did 1 year ago.
SHL has more shares outstanding than it did 5 years ago.
SHL has a better debt/assets ratio than last year.
SHL.DE Yearly Shares OutstandingSHL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SHL.DE Yearly Total Debt VS Total AssetsSHL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.00 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.00) is comparable to the rest of the industry.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.45, SHL perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SHL underperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Altman-Z 2
ROIC/WACC1.2
WACC6.37%
SHL.DE Yearly LT Debt VS Equity VS FCFSHL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
SHL has a worse Current ratio (1.11) than 73.85% of its industry peers.
A Quick Ratio of 0.79 indicates that SHL may have some problems paying its short term obligations.
SHL has a worse Quick ratio (0.79) than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
SHL.DE Yearly Current Assets VS Current LiabilitesSHL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
Measured over the past years, SHL shows a quite strong growth in Revenue. The Revenue has been growing by 10.08% on average per year.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%

3.2 Future

The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.85% on average per year.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
EPS Next 5Y8.79%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y5.31%
Revenue Next 5Y5.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHL.DE Yearly Revenue VS EstimatesSHL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SHL.DE Yearly EPS VS EstimatesSHL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.71, SHL is valued on the expensive side.
Based on the Price/Earnings ratio, SHL is valued cheaper than 86.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (26.37), we can say SHL is valued slightly cheaper.
SHL is valuated correctly with a Price/Forward Earnings ratio of 16.59.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 67.69% of the companies are valued more expensively.
SHL is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.71
Fwd PE 16.59
SHL.DE Price Earnings VS Forward Price EarningsSHL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SHL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SHL is cheaper than 64.62% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaply inside the industry as 87.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.59
EV/EBITDA 13.47
SHL.DE Per share dataSHL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.61
PEG (5Y)1.57
EPS Next 2Y9.66%
EPS Next 3Y9.45%

6

5. Dividend

5.1 Amount

SHL has a Yearly Dividend Yield of 2.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.15, SHL pays a better dividend. On top of this SHL pays more dividend than 81.54% of the companies listed in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
SHL.DE Yearly Dividends per shareSHL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
SHL.DE Yearly Income VS Free CF VS DividendSHL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SHL.DE Dividend Payout.SHL.DE Dividend Payout, showing the Payout Ratio.SHL.DE Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

FRA:SHL (12/3/2025, 5:36:15 PM)

42.33

-0.34 (-0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.75B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target57.22 (35.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-7.54%
PT rev (3m)-7.54%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 17.71
Fwd PE 16.59
P/S 2.04
P/FCF 17.59
P/OCF 13.52
P/B 2.65
P/tB N/A
EV/EBITDA 13.47
EPS(TTM)2.39
EY5.65%
EPS(NY)2.55
Fwd EY6.03%
FCF(TTM)2.41
FCFY5.68%
OCF(TTM)3.13
OCFY7.4%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.61
PEG (5Y)1.57
Graham Number29.33
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROCE 9.97%
ROIC 7.65%
ROICexc 8.31%
ROICexgc 43.54%
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
FCFM 11.61%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Debt/EBITDA 2.54
Cap/Depr 63.12%
Cap/Sales 3.5%
Interest Coverage 7.04
Cash Conversion 79.23%
Profit Quality 126.59%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 2
F-Score8
WACC6.37%
ROIC/WACC1.2
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y5.31%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y17.45%
EBIT Next 5Y14.02%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / SHL.DE FAQ

What is the fundamental rating for SHL stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.


What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SIEMENS HEALTHINEERS AG?

SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SHL stock?

The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.71 and the Price/Book (PB) ratio is 2.65.


Can you provide the dividend sustainability for SHL stock?

The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.